Bactiquant A/S OMXCOP:BACTIQ:
CONFIRMS NEW SUPPLY AGREEMENT FOR PHARMA SEGMENT
Bactiquant Confirms New Supply Deal For Pharma Segment
Story so far
Earlier from BactiQuant
- Bactiquant Gets Framework Order For Supply Of Analytical Chemistry
- BactiQuant A/S: Quarterly Trading Report 2025 Q3
Later from BactiQuant
- Bactiquant Receives Order In Australia
- Bactiquant A/S - admission to trading of new shares
- BACTIQ: 2025 revenue rose 16% to DKK 8.3 million, with strong Pharma growth and robust liquidity
- BACTIQ: Revenue up 16% to DKK 8.3m; Pharma and Aquaculture segments led growth; liquidity secured
- BACTIQ: Q1 2026 revenue up 29% year-over-year, driven by recurring Pharma sales and new hospital hardware deal
Follow BactiQuant into a list and get an email when it puts out news.
Follow BactiQuant